We would like to thank all our speakers, sponsors and most importantly delegates for contributing to and participating in EUROLEUK2020. The congress was a great success and we were delighted to welcome over 1,200 participants from 91 countries worldwide!
We look forward to ‘seeing’ you again at The 2nd Virtual Congress on Controversies in Leukemias (EUROLEUK2021) which will take place 28-29 October 2021. Visit Euroleuk2021 for details…
Alessandro Isidori, MD, PhD,
Hematology and Stem Cell Transplant Center
Marche Nord Hospital – Pesaro – Italy
CALL FOR ABSTRACTS
Meet our Esteemed Invited Speakers
MLL Munich Leukemia Laboratory, Germany
Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, Italy
Haematology Division of Cancer and Genetics, Cardiff University, UK
Director of the R&D department, Celyad, Belgium
|*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)|
|Chair: Prof Alessandro Isidori, Italy|
|Speaker: Dr Donal McLornan, UK|
We look forward to hearing from you.